Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

The agency is changing the standard of evidence required for Covid-19 vaccine approval in the US, Dr. Vinay Prasad, the new ...

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.

The vaccine, Nuvaxovid, is the third coronavirus shot to gain full approval, joining vaccines from Pfizer and Moderna. It has ...

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...